Chiltern International
Contact Details
Chiltern171 Bath Road
Slough
Berkshire
SL1 4AA
Phone number: +44 (0)1753 512 000
Fax number: +44 (0)1753 511 116
Web address: http://www.chiltern.com
Email address: info@chiltern.com
Company Profile
Established in London in 1982, Chiltern is a leading global Contract Research Organization. The company has extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern employs more than 1400 people, with 28 offices across the Americas, Europe and Asia. Chiltern provides services including
Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.
Date established: 1982
Number of local staff: 1400
Additional services
- Resourcing Solutions
Years of recruiting talented people all over the world have led us to a unique position. We have a database of motivated and skilled people at all levels of experience in the Americas, Europe and Asia. Using this resource, we supply staff in a wide range of disciplines, on a contract basis to the pharmaceutical industry around the world. In addition to short and long-term contracts, we also offer senior personnel on an interim basis, and are able to assist with all your permanent resourcing needs.
Expertise
- Early Phase
The dedicated full-time team of physicians, registered nurses and scientists that make up Chiltern’s Clinical Research Unit approach every study with four criteria in mind: safety, precision, quality and compliance. Specialists from project managers to physicians have input at every stage, from planning through study completion.
- Global Clinical Development
Chiltern’s Global Clinical Monitoring personnel are located on four continents to ensure precise procedures, and strict quality controls are practised at all times. Dedicated local line managers recruit, train and manage clinical monitoring staff to global standards and monitor quality against Federal and ICH good clinical practice standards. Our emphasis on planning, clear communication and team cooperation across disciplines makes our added value evident from the day a project begins.
- Late Phase
Our Global Late Phase Group of specialist project managers and experienced
clinical development professionals are focused on providing specific services designed to support products from their launch through to market planning. Our expert teams provide Phase IIIb and IV, Non-Interventional, Observational, Epidemiology, Investigator- Initiated trials and Registry services, in both national and international
markets. Biometrics Chiltern Biometrics work alongside sponsors to optimize the value of ourexpertise to their study and objectives. Dedicated Electronic Data Capture
(EDC) staff ensure the most beneficial fit between the sponsor and the investigator
sites. Full, ongoing statistical support is provided by our Biostatisticians and provided in electronic format for seamless incorporation in interim analyses for Data Monitoring Committees (DMC), clinical study reports and electronic submissions for regulatory filings. Our Medical Writing teams are fully experienced in reporting to the highest international guidelines.
- Medical and Regulatory Affairs
Our Regulatory and Medical professionals keep track of and anticipate developments
globally. Their contribution to projects can range from the strategic planning of critical paths to applying for clinical trial and marketing authorizations. They are widely experienced in providing due diligence programs and full pharmacovigilance services for both licensed and unlicensed products. The knowledge base within Chiltern’s
Regulatory and Medical Affairs Team ensures that studies always have high standards of scientific and medical representation, to meet the requirements of
the relevant competent authorities.
Key Contacts
|
Executive Director, Strategic Development, Europe
|
Chiltern International
- You must register/login in order to post into this group.
- Add user to this company







